(Q40925870)

24 September 2017

1 reference

title

Thalidomide: rationale for renewed use in immunological disorders (English)

1 reference

24 September 2017

0 references

2

G Ehninger

1 reference

24 September 2017

U Schuler

1

1 reference

24 September 2017

1 June 1995

1 reference

24 September 2017

1 reference

24 September 2017

12

1 reference

24 September 2017

364-369

1 reference

24 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199512060-00002

24 September 2017

0 references

cites work

Inhibition of PMN leukocytes chemotaxis by thalidomide

1 reference

12 December 2020

Effects of thalidomide on the generation of oxygen intermediates by zymosan-stimulated normal polymorphonuclear leukocytes

1 reference

12 December 2020

Langerhans-cell histiocytosis in the adult: regressive parotid involvement following thalidomide therapy

1 reference

12 December 2020

Thalidomide: 35 years on and still deforming

1 reference

12 December 2020

Treatment of Behçet's disease with thalidomide

1 reference

12 December 2020

The feasibility of altering the immunogenicity of grafts

1 reference

12 December 2020

Thalidomide neuropathy

1 reference

12 December 2020

The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum Leprosum

1 reference

12 December 2020

Thalidomide for the treatment of chronic graft-versus-host disease

1 reference

12 December 2020

The effect of thalidomide on experimental autoimmune myasthenia gravis

1 reference

12 December 2020

THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS

1 reference

12 December 2020

Induction of morphological differentiation in the human leukemic cell line K562 by exposure to thalidomide metabolites

1 reference

12 December 2020

Treatment of refractory rheumatoid arthritis--the thalidomide experience

1 reference

12 December 2020

Effects of thalidomide and its derivatives on human leucocytes cultured in vitro

1 reference

12 December 2020

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

1 reference

12 December 2020

Expression of adhesion molecules in leprosy lesions

1 reference

12 December 2020

Thalidomide: treatment of severe recurrent aphthous stomatitis in patients with AIDS

1 reference

12 December 2020

Thalidomide, orogenital ulcers, and the risk of teratogenesis

1 reference

12 December 2020

Determination of thalidomide in plasma and blood by high-performance liquid chromatography: avoiding hydrolytic degradation

1 reference

12 December 2020

Thalidomide for the therapy of graft-versus-host disease following allogeneic bone marrow transplantation

1 reference

12 December 2020

The potential use of thalidomide in the therapy of graft-versus-host disease--a review of clinical and laboratory information

1 reference

12 December 2020

Thalidomide inhibits the replication of human immunodeficiency virus type 1

1 reference

12 December 2020

Combination thalidomide and cyclosporine for cardiac allograft rejection. Comparison with combination methylprednisolone and cyclosporine

1 reference

12 December 2020

Thalidomide's effectiveness in erythema nodosum leprosum is associated with a decrease in CD4+ cells in the peripheral blood

1 reference

12 December 2020

Thalidomide for chronic graft-versus-host disease in children

1 reference

12 December 2020

Cellular immune effects of thalidomide in actinic prurigo

1 reference

12 December 2020

Inhibition of de novo IgM antibody synthesis by thalidomide as a relevant mechanism of action in leprosy

1 reference

12 December 2020

Another chance for thalidomide?

1 reference

12 December 2020

Proposed mechanisms of action in thalidomide embryopathy

1 reference

12 December 2020

Thalidomide-induced neuropathy in rheumatoid arthritis patients

1 reference

12 December 2020

Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations

1 reference

12 December 2020

Successful treatment of adult's Langerhans cell histiocytosis with thalidomide. Report of two cases and literature review

1 reference

12 December 2020

Treatment of resistant aphthous ulceration with thalidomide in patients positive for HIV antibody

1 reference

12 December 2020

Thalidomide enhances superoxide anion release from human polymorphonuclear and mononuclear leukocytes

1 reference

12 December 2020

Development of polyneuropathy during thalidomide therapy

1 reference

12 December 2020

Treatment and prevention of acute graft-versus-host disease with thalidomide in a rat model

1 reference

12 December 2020

Thalidomide and the immune system 2. Changes in receptors on blood cells of a healthy volunteer

1 reference

12 December 2020

Thalidomide treatment for chronic graft-versus-host disease

1 reference

12 December 2020

Thalidomide neuropathy incidence and clinico-electrophysiologic findings in 42 patients

1 reference

12 December 2020

Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions

1 reference

12 December 2020

Beneficial effect of thalidomide and ciclosporin combination in heterotopic cardiac transplantation in rats

1 reference

12 December 2020

Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis

1 reference

12 December 2020

Use of thalidomide in leprosy

1 reference

12 December 2020

Inhibition of tumor necrosis factor-alpha by thalidomide in magnesium deficiency

1 reference

12 December 2020

Tumor necrosis factor production in patients with leprosy

1 reference

12 December 2020

Effect of Thalidomide on the Graft versus Host Reaction

1 reference

12 December 2020

Improvements in Solubility and Stability of Thalidomide upon Complexation with Hydroxypropyl-β-Cyclodextrin

1 reference

12 December 2020

Effect of thalidomide on survival of skin homografts in rabbits

1 reference

12 December 2020

Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients

1 reference

12 December 2020

Thalidomide for systemic lupus erythematosus

1 reference

12 December 2020

Thalidomide as therapy for intestinal chronic GVHD

1 reference

12 December 2020

Adhesion receptors of the immune system

1 reference

12 December 2020

Thalidomide effects in Behçet's syndrome and pustular vasculitis

1 reference

12 December 2020

Enhancement of phorbol ester-induced production of tumor necrosis factor alpha by thalidomide

1 reference

12 December 2020

Thalidomide prolongs graft survival in rat cardiac transplants

1 reference

12 December 2020

Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite

1 reference

12 December 2020

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

1 reference

12 December 2020

Determination of thalidomide and its major metabolites by high-performance liquid chromatography

1 reference

12 December 2020

Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial

1 reference

12 December 2020

Thalidomide derivatives and the immune system. I. Changes in the pattern of integrin receptors and other surface markers on T lymphocyte subpopulations of marmoset blood.

1 reference

12 December 2020

10.2165/00002018-199512060-00002

Identifiers

DOI

1 reference

PubMed ID

8527011

Dimensions Publication ID

24 September 2017

0 references

1 reference

PubMed ID

8527011